[1]
N. K. Al-Quriashi and S. O. Essa, “0.1 Second versus 0.2 Second pulse duration of Frequency Doubled Nd: YAGLaser in treatment of Clinically Significant Diabetic Maculopathy”., JFacMedBagdad, vol. 51, no. 1, pp. 112–115, Apr. 2009, doi: 10.32007/jfacmedbagdad.5111196.